PART I. FINANCIAL INFORMATION This section presents eHealth's unaudited condensed consolidated financial statements and management's discussion and analysis for Q1 2023 [ITEM 1. FINANCIAL STATEMENTS (Unaudited)](index=7&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS) This section presents eHealth's unaudited condensed consolidated financial statements for Q1 2023 and 2022, covering balance sheets, comprehensive loss, equity, cash flows, and detailed notes [Condensed Consolidated Balance Sheets](index=7&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) The Condensed Consolidated Balance Sheets show a slight decrease in total assets and stockholders' equity from December 31, 2022, to March 31, 2023, while cash and cash equivalents increased | Metric | March 31, 2023 (in thousands) | December 31, 2022 (in thousands) | | :-------------------------------- | :----------------------------- | :----------------------------- | | Cash and cash equivalents | $180,633 | $144,401 | | Total current assets | $420,664 | $401,084 | | Total assets | $1,083,034 | $1,112,611 | | Total current liabilities | $51,467 | $60,565 | | Total liabilities | $183,672 | $198,372 | | Convertible preferred stock | $271,454 | $263,284 | | Total stockholders' equity | $627,908 | $650,955 | [Condensed Consolidated Statements of Comprehensive Loss](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Loss) eHealth reported a significant reduction in total revenue and net loss for Q1 2023 compared to Q1 2022, driven by decreases in commission and other revenue, alongside substantial reductions in operating costs and expenses | Metric | Three Months Ended March 31, 2023 (in thousands) | Three Months Ended March 31, 2022 (in thousands) | Change (YoY) | | :----------------------------------- | :--------------------------------------------- | :--------------------------------------------- | :----------- | | Total revenue | $73,723 | $105,250 | (30)% | | Total operating costs and expenses | $96,617 | $144,964 | (33)% | | Loss from operations | $(22,894) | $(39,714) | 42% | | Net loss | $(19,878) | $(32,742) | 39% | | Net loss attributable to common stockholders | $(28,048) | $(39,960) | 30% | | Basic and diluted EPS | $(1.01) | $(1.46) | 31% | - Commission revenue decreased by **28% to $68,003 thousand** in Q1 2023 from $93,850 thousand in Q1 2022, while other revenue decreased by **50% to $5,720 thousand** in Q1 2023[20](index=20&type=chunk) - Marketing and advertising expenses decreased by **44% to $32,899 thousand** in Q1 2023, and customer care and enrollment expenses decreased by **36% to $26,957 thousand** in Q1 2023[20](index=20&type=chunk) [Condensed Consolidated Statements of Stockholders' Equity](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Stockholders'%20Equity) Total stockholders' equity decreased from $650,955 thousand at December 31, 2022, to $627,908 thousand at March 31, 2023, primarily due to net loss and preferred stock dividends | Metric | December 31, 2022 (in thousands) | March 31, 2023 (in thousands) | | :-------------------------------- | :----------------------------- | :----------------------------- | | Total Stockholders' Equity | $650,955 | $627,908 | | Retained Earnings | $73,799 | $45,751 | | Additional Paid-in Capital | $777,187 | $782,065 | - Net loss for Q1 2023 was **$(19,878) thousand**, contributing to the decrease in retained earnings[22](index=22&type=chunk) - Stock-based compensation added **$5,306 thousand** to additional paid-in capital during Q1 2023[22](index=22&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=10&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) eHealth generated **$60.8 million** in net cash from operating activities in Q1 2023, an increase from $47.1 million in Q1 2022, primarily due to a significant decrease in commissions receivable | Cash Flow Activity | Three Months Ended March 31, 2023 (in thousands) | Three Months Ended March 31, 2022 (in thousands) | | :----------------------------------- | :--------------------------------------------- | :--------------------------------------------- | | Net cash provided by operating activities | $60,803 | $47,112 | | Net cash provided by (used in) investing activities | $(24,240) | $26,121 | | Net cash provided by (used in) financing activities | $(439) | $65,373 | | Net increase in cash, cash equivalents and restricted cash | $36,232 | $138,637 | - The increase in operating cash flow in Q1 2023 was largely driven by an **$82.5 million decrease** in contract assets – commissions receivable[27](index=27&type=chunk) - Investing activities in Q1 2023 included **$22.0 million** in purchases of marketable securities and **$2.2 million** in capitalized internal-use software[27](index=27&type=chunk) [Notes to Condensed Consolidated Financial Statements](index=11&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) The notes provide detailed disclosures on eHealth's business, accounting policies, revenue disaggregation, supplemental financial information, fair value measurements, equity, debt, and income taxes [Note 1 – Summary of Business and Significant Accounting Policies](index=11&type=section&id=Note%201%20%E2%80%93%20Summary%20of%20Business%20and%20Significant%20Accounting%20Policies) eHealth operates as a leading private online health insurance marketplace, offering a technology and service platform for consumer engagement, education, and enrollment in various health insurance products - eHealth operates as a leading private online health insurance marketplace, offering a technology and service platform for consumer engagement, education, and enrollment in various health insurance products from approximately **200 carriers** across all 50 states and D.C[30](index=30&type=chunk) - The company's platform supports an omnichannel approach, allowing consumers to use services online, by telephone with licensed agents, or through hybrid online assisted interactions[30](index=30&type=chunk) - The condensed consolidated financial statements are unaudited and prepared in accordance with U.S. GAAP for interim financial information, reflecting normal recurring adjustments[33](index=33&type=chunk) [Note 2 – Revenue](index=13&type=section&id=Note%202%20%E2%80%93%20Revenue) This note details eHealth's revenue disaggregation by product category, highlighting a significant decrease in Medicare and sponsorship revenue, partially offset by growth in Individual and Family and Small Business segments | Revenue Category | Three Months Ended March 31, 2023 (in thousands) | Three Months Ended March 31, 2022 (in thousands) | Change (YoY) | | :----------------------- | :--------------------------------------------- | :--------------------------------------------- | :----------- | | Medicare | $58,963 | $85,710 | (31.2)% | | Individual and Family | $4,006 | $3,126 | 28.2% | | Ancillary | $2,422 | $2,831 | (14.4)% | | Small Business | $4,873 | $3,483 | 39.9% | | Commission Bonus and Other | $(2,261) | $(1,300) | (73.9)% | | Total Commission Revenue | $68,003 | $93,850 | (27.5)% | | Sponsorship and Advertising Revenue | $4,943 | $10,645 | (53.6)% | | Total Other Revenue | $5,720 | $11,400 | (49.9)% | | Total Revenue | $73,723 | $105,250 | (30.0)% | - Medicare commission revenue from members approved during the period decreased from **$84,283 thousand** in Q1 2022 to **$56,617 thousand** in Q1 2023[42](index=42&type=chunk) - Individual, Family and Small Business segment commission revenue increased from **$9,516 thousand** in Q1 2022 to **$11,334 thousand** in Q1 2023[42](index=42&type=chunk) [Note 3 – Supplemental Financial Statement Information](index=14&type=section&id=Note%203%20%E2%80%

Financial Data and Key Metrics Changes - Fourth quarter revenue was $196.3 million, down 19% year-over-year, reflecting an intentional decision to focus on profitable growth [17][72] - Fourth quarter GAAP net income was $20.7 million compared to a net loss of $32.2 million in Q4 a year ago [58] - Adjusted EBITDA for the fourth quarter increased by 76% year-over-year to $49.5 million from $28.2 million [40][72] - Full year 2022 GAAP net loss was $88.7 million, with adjusted EBITDA of negative $41.7 million [58] Business Line Data and Key Metrics Changes - Medicare segment revenue for Q4 was $180.4 million, down 22% year-over-year, while segment profit increased by 56% to $53.2 million [55] - Fourth quarter Medicare Advantage lifetime values (LTV) grew 2% year-over-year, while total variable acquisition costs per approved member declined by 18% [54][71] - Individual, family, and small business (IFP) segment revenue was $15.9 million, an increase of 23% year-over-year, driven by tail revenue [112] Market Data and Key Metrics Changes - Estimated Medicare Advantage paying membership at year-end was approximately 646,000 lives, up 2% from 2021 [56] - Total estimated Medicare membership, including Med Sup and prescription drug plans, was 976,000 lives, also up 2% year-over-year [56] Company Strategy and Development Direction - The company aims to diversify revenue streams beyond Medicare Advantage, focusing on sustainable profitability and improved liquidity [4][44] - Strategic initiatives include enhancing consumer experience, improving conversion rates, and expanding dedicated carrier arrangements [76][80] - The company plans to hold its first Investor Day since 2019 to discuss long-term strategic and financial goals [16] Management's Comments on Operating Environment and Future Outlook - Management noted a shift in the industry towards prioritizing sustainable profitability over growth at all costs, indicating a potential inflection point in the Medicare distribution market [14] - The company expects to achieve approximately 6% revenue growth in 2023, with significant improvements in profitability driven by cost reduction programs [18][92] - Management expressed confidence in maintaining sufficient liquidity to execute 2023 operating plans [62] Other Important Information - The company implemented a cost reduction program in April 2022, which resulted in a significant reduction in operating expenses [57][113] - The cash benefit from investments made to resume enrollment growth will not be felt until Q1 of 2024, with expectations of breakeven on an operating cash flow basis by March 31, 2024 [7] Q&A Session Summary Question: What is the approach to retaining agents outside the busy AEP and OEP season? - Management emphasized a more prudent approach to variable costs for marketing activities while maintaining agent productivity through improved lead quality [100][124] Question: How does the company view the diversification of revenue streams with dedicated carrier segments? - Management clarified that dedicated carrier arrangements will not compete with traditional Medicare Advantage business and will enhance the company's role as a neutral distribution channel [104][105] Question: What are the expectations regarding cash flow and potential capital raises? - Management indicated confidence in cash flow projections and the sufficiency of liquidity to meet operational needs without immediate capital raises [106][122]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number: 001-33071 _____________________________________________ EHEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 56- ...

eHealth, Inc. (NASDAQ:EHTH) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Eli Newbrun-Mintz - Senior Investor Relations Manager Fran Soistman - Chief Executive Officer Christine Janofsky - Chief Financial Officer Conference Call Participants Tobey Sommer - Truist Securities George Hill - Deutsche Bank Ben Hendrix - RBC Capital Markets Daniel Grosslight - Citi Operator Good afternoon, everyone, and welcome to the eHealth, Inc. conference call to discuss the company's Third ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 _____________________________________________ EHEALTH, INC. (Exact name of registrant as specified in its charter) _____________ ...

eHealth, Inc. (NASDAQ:EHTH) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Eli Newbrun-Mintz - Senior Investor Relations Manager Fran Soistman - Chief Executive Officer and Director Christine Janofsky - Chief Financial Officer Roman Rariy - Chief Operating Officer and Chief Transformation Officer Conference Call Participants Elizabeth Anderson - Evercore Daniel Grosslight - Citigroup Tobey Sommer - Truist Securities Ben Hendrix - RBC Capital Markets Operator Good afternoon, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 _____________________________________________ EHEALTH, INC. (Exact name of registrant as specified in its charter) __________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33071 _____________________________________________ EHEALTH, INC. (Exact name of registrant as specified in its charter) _________________ ...

EHealth, Inc. (NASDAQ:EHTH) Q1 2022 Earnings Conference Call May 3, 2022 5:00 PM ET Company Participants Fran Soistman – Chief Executive Officer Christine Janofsky – Chief Financial Officer Phillip Morelock – Chief Digital Officer Eli Newbrun-Mintz – Senior Investor Relations Manager Robert Hurley – Chief Revenue Officer Conference Call Participants Elizabeth Anderson – Evercore ISI Jonathan Young – Credit Suisse George Sutton – Craig-Hallum Daniel Grosslight – Citi Operator Good afternoon, everyone and we ...

eHealth, Inc. (NASDAQ:EHTH) Q4 2021 Earnings Conference Call March 1, 2022 8:30 AM ET Company Participants Eli Newbrun-Mintz – Investor Relations Manager Fran Soistman – Chief Executive Officer Christine Janofsky – Chief Financial Officer Phillip Morelock – Chief Digital Officer Conference Call Participants Elizabeth Anderson – Evercore ISI George Sutton – Craig-Hallum Jailendra Singh – Credit Suisse Steven Valiquette – Barclays Tobey Sommer – Truist George Hill – Deutsche Bank Operator Good morning, everyo ...